Recent studies reveal that splenic macrophage subsets (e.g., CD206 + Tim4+) establish a “dual-barrier” mechanism through TGF-β1-dependent immunosuppression and FcγRIII-mediated tumor clearance (11–14). The gene discussed is TGFB1; the disease is neoplasm.